Biological Trace Element Research

, Volume 67, Issue 2, pp 151–163 | Cite as

Thyroid functions in lithium-treated psychiatric patients

A Cross-Sectional Study
  • S. D. Deodhar
  • B. Singh
  • C. M. Pathak
  • P. Sharan
  • P. Kulhara
Original Articles

Abstract

In the present cross-sectional study, thyroid functions (viz. thyroid radioiodine uptake [RAIU] and serum T3, T4, and thyroidstimulating hormone [TSH]) were evaluated in 24 healthy controls and 132 outdoor affective disorder patients. Eleven of these patients were to receive lithium (Li) and the remaining 121 patients were at different stages of Li treatment ranging from 0.7 to 240 mo. RAIU was found to increase significantly throughout the Li therapy and was associated with the corresponding rise in TSH levels. In totality, Li treatment induced subclinical hypothyroidism in 51/132 (39%) of patients. However, 8/51 patients who belonged to known iodine-deficient belt had abnormally high TSH (range 15.2–76.0 uIU/mL), low T4 (5.3 ± 2.5 Hg/dL), and normal T3 and at least 4 of these 8 patients were clinically hypothyroid. T4 levels declined significantly (p < 0.05) with Li treatment ranging from 61 to 240 mo as compared to the corresponding values in the pre-Li group. The T3/T4 ratio was found to be significantly higher with Li treatment ranging from 0.7 to 6 mo in comparison with the pre-Li group and this value returned to base levels after long-term Li therapy. High T3 and T4 were observed in 13% and 12% of the patients, respectively, as compared to the corresponding control values.

Index entries

Thyroid functions affective disorder lithium treatment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    B. M. Wagner, T. B. Copper, and N. S. Klin, Structural basis of lithium,Int. Pharmacopsychiatr.5, 208–218 (1970).Google Scholar
  2. 2.
    F. A. Freyhan, R. A. O’Connell, and J. A. Mayo, Treatment of mood disorders with lithium carbonate,Int. Pharmacopsychiatr.5, 137–148 (1970).Google Scholar
  3. 3.
    J. W. Jefferson, Lithium: The present and the future,J. Clin. Psychiatry 51(8), 4–8 (1990).PubMedGoogle Scholar
  4. 4.
    G. Kallner and U. Petterson, Renal, thyroid and parathyroid function during lithium treatment: Laboratory tests in 207 people treated for 1–30 years,Acta Psychiatr. Scand.91, 48–51 (1995).PubMedCrossRefGoogle Scholar
  5. 5.
    M. Schou, A. Amdisen, S. E. Jensen, and T. Olsen, Occurrence of goitre during lithium treatment,Br. Med. J. 3, 710–713 (1968).PubMedGoogle Scholar
  6. 6.
    G. Sedvall, B. Jonsson, U. Petterson, and H. Levin, Effects of lithium salts on plasma protein bound iodine and uptake of radioiodine in thyroid gland of man and rat,Life Sci. 7, 1257–1264 (1968).CrossRefGoogle Scholar
  7. 7.
    B. Shopsin, Effects of lithium on thyroid function—a review,Dis. Nerv. Syst. 31, 237–244 (1970).PubMedGoogle Scholar
  8. 8.
    G. Rogers, W. Burke, J. Himmelhoch, R. Spencer, and J. Hershman, Effect of lithium on thyroid function,J. Clin. Endocrinol.32, 647–652 (1971).Google Scholar
  9. 9.
    V. Lauridsen, C. Kirkegaard, and J. Nerup, Lithium and the pituitary-thyroid axis in normal subjects,J. Clin. Endocr. Metab. 39, 383–385 (1974).PubMedCrossRefGoogle Scholar
  10. 10.
    C. Hoschl, Lithium influence on TSH response to TRH in depressed patients,Physicologia 30, 89–90 (1981).Google Scholar
  11. 11.
    K. Bakker, The influence of lithium carbonate on the hypothalamic-pituitary-thyroid axis,Agressologie 23, 89–93 (1982).PubMedGoogle Scholar
  12. 12.
    H. Perrilid, K. Madsen, and M. C. Hansen, Irreversible myxoedema after lithium carbonate,Br. Med. J. 76, 1108–1109. (1978).Google Scholar
  13. 13.
    S. Cairns, R. Wolman, and J. Lewis, persistent nephrogenic diabetes insipidus, hyperthyroidism and hypothyroidism after lithium treatment,Br. Med. J. 290, 516–517 (1985).CrossRefGoogle Scholar
  14. 14.
    D. Myers D. R. Carter, B. Burns, A. Armond, S. Hussain, and V. Chengapa, A prospective study of the effects of lithium on thyroid function and on the prevalence of antithyroid antibodies,Psychol. Med. 15, 55–61 (1985).PubMedGoogle Scholar
  15. 15.
    R. Hullin, R. McDonald, and M. Allsopp, Further report on prophylactic lithium in recurrent affective disorders,Br. J. Psychiatry 126, 281–286 (1975).PubMedGoogle Scholar
  16. 16.
    J. Calabrese, D. Gulledge, K. Hahn, R. Skwerer, M. Kotz, O. Schumacher, et al., Autoimmune thyroiditis in manic depressive patients treated with lithium,Am. J. Psychiatry 142, 1318–1321 (1985).PubMedGoogle Scholar
  17. 17.
    M. Crowe, G. Lloyd, S. Bloch, and R. Rosser, Hypothyroidism in patients treated with lithium, a review and two case reports,Psychol. Med. 3, 337–342 (1973).PubMedCrossRefGoogle Scholar
  18. 18.
    M. Schoenberg, T. Ts’o, and A. Meisel, Single case study—Grave’s disease manifesting after maintainence lithium,J. Clin. Psychiatry 167, 575–577 (1979).Google Scholar
  19. 19.
    P. Rabin and D. Evans, Exophthalmos and elevated tyroxine levels in association with lithium therapy,J. Clin. Psychiatry 42, 398–400 (1981).PubMedGoogle Scholar
  20. 20.
    J. P. Kushner and P. Vestergaard, Lithium-thyroid interactions, inLithium and the Endocrine System, F. N. Johnson, ed., Karger, Basel, pp. 74–93 (1988).Google Scholar
  21. 21.
    P. W. Brown and E. F. Legg, The estimation of lithium in serum,Ann. Clin. Biochem. 7, 13–17 (1970).Google Scholar
  22. 22.
    K. Maarbjerg, P. Vestergaard, and M. Scou, Changes in serum thyroxine (T4) and serum thyroid stimulating hormone (TSH) during prolonged lithium treatment,Acta Psychiatr. Scand.75, 217–221 (1987).PubMedCrossRefGoogle Scholar
  23. 23.
    I. Tansbol, C. Christiansen, and P. Baastrup, Endocrine effects of lithium: hypothyroidism, its prevalence in long term treated patients,Acta Endocr. Copenh. 87, 759–767 (1978).Google Scholar
  24. 24.
    J. Lazarus, R. John, E. Bennie, R. Chalmers, and G. Crockett, Lithium therapy and thyroid function—a long term study,Psychol. Med. 11, 85–92 (1981).PubMedGoogle Scholar
  25. 25.
    A. Amdisen and C. Anderson, Lithium treatment of thryoid function—a survey of 237 patients in long term lithium treatment,Pharmacopsychiatry 15, 149–155 (1982).Google Scholar
  26. 26.
    H. Perrilid, L. Hegedus, and K. Arnung, Sex related goitrogenic effect of lithiumcarbonate in healthy young subjects,Acta Endocr. Copenh. 106, 203–208 (1984).Google Scholar
  27. 27.
    J. J. W. Alastair, Drug therapy,New Eng. J. Med. 333(25), 1688–1694 (1995).CrossRefGoogle Scholar
  28. 28.
    P. Rabin and D. Evans, Exophthalmos and elevated thyroxine levels in association with lithium therapy,J. Clin. Psychiatry 42, 398–400 (1981).PubMedGoogle Scholar
  29. 29.
    C. Goplan,Nutrition Problems in South-East Asia, SEARO Regional Health Papers WHO Publications15, World Health Organization, Geneva (1987).Google Scholar
  30. 30.
    A. Bocchetta, F. Bernardi, and M. Pedditzi, Thyroid abnormalities during lithium treatment,Acta Psychiatr. Scand.83, 193–198 (1991).PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 1999

Authors and Affiliations

  • S. D. Deodhar
    • 1
  • B. Singh
    • 1
  • C. M. Pathak
    • 2
  • P. Sharan
    • 3
  • P. Kulhara
    • 3
  1. 1.Departments of Nuclear MedicinePost Graduate Institute of Medical Education and ResearchChandigarhIndia
  2. 2.Departments of BiophysicsPost Graduate Institute of Medical Education and ResearchChandigarhIndia
  3. 3.Departments of PsychiatryPost Graduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations